Recent Progress in Structures and Functions of Hepatitis C Virus NS3/4A Proteins
Viruses · 2026
DOI: 10.3390/v18020233 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Viruses, 2026. Verfasst von Keyang Huang und 3 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Animal Biotech Breeding, College of Biological Sciences, China Agricultural University, Beijing 100193, China. Hauptthemen laut MEDLINE: Viral Nonstructural Proteins, Hepacivirus, Carrier Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, National Key R&D Program of China.
Abstract (Originalsprache)
Hepatitis C virus (HCV) chronically infects over 50 million people worldwide and poses a significant risk to global health. The HCV NS3/4A complex, a bifunctional enzyme comprising a protease and a helicase domain, is indispensable for viral replication and immune evasion, making it a pivotal target for direct-acting antiviral agents (DAAs). Here, we summarize its structural features, functional mechanisms, and implications in drug design and protein engineering (e.g., nanopore sequencing applications). The NS3 protease domain is activated by the NS4A cofactor, which mediates viral polyprotein processing and relies on a zinc-binding site for structural stability. The C-terminal helicase domain catalyzes ATP-dependent 3′→5′ unwinding, and allosteric crosstalk between the protease and helicase domains dynamically modulates the enzymatic activity, balancing unwinding velocity and processivity. Beyond supporting viral replication, NS3/4A cleaves MAVS to abolish RIG-I/MDA5 signaling but spares TRIF, leaving TLR3-mediated immunity intact; it also modulates host lipid and iron metabolism, contributing to HCV pathogenesis. Notably, structural and functional studies of NS3/4A lay a solid theoretical foundation for developing novel therapeutic strategies. Currently, DAAs targeting NS3/4A have achieved high sustained virologic response rates; however, resistance-associated substitutions remain a major clinical challenge, particularly in genotype 3 infections. Emerging therapeutic strategies targeting NS3/4A include allosteric inhibition and proteolysis-targeting chimeras (PROTACs)-mediated degradation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Animal Biotech Breeding, College of Biological Sciences, China Agricultural University, Beijing 100193, China.
- State Key Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.
- University of Chinese Academy of Sciences, Beijing 100101, China.
ORCID-Profile: Zhongzhou Chen
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- National Key R&D Program of China
Zitieren
APA
Huang, K., Zhang, M., Huang, Y., & Chen, Z. (2026). Recent Progress in Structures and Functions of Hepatitis C Virus NS3/4A Proteins. Viruses. https://doi.org/10.3390/v18020233
Vancouver
Huang K, Zhang M, Huang Y, Chen Z. Recent Progress in Structures and Functions of Hepatitis C Virus NS3/4A Proteins. Viruses. 2026. doi:10.3390/v18020233
BibTeX
@article{Huang2026,
author = {Huang, Keyang and Zhang, Manfeng and Huang, Yihua and Chen, Zhongzhou},
title = {Recent Progress in Structures and Functions of Hepatitis C Virus NS3/4A Proteins},
journal = {Viruses},
year = {2026},
doi = {10.3390/v18020233}
}
EUVIMED